SCHEMBL7143573

SCHEMBL7143573

CC(=O)c1cc(S(N)(=O)=O)ccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 12/20 0.55
CA2 P00918 12/20 0.55
CA9 Q16790 11/20 0.55
CA12 O43570 7/20 0.55
ALDH1A1 P00352 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP2C9 P11712 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
PHLPP2 Q6ZVD8 1/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 1/20 0.49
GAA P10253 2/20 0.48
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
GLO1 Q04760 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141964 0.87 POLB (0.49) CA1CA2CA9CA12KDM4E
SCHEMBL1577295 0.85 LMNA (0.51) ALDH1A1HSD17B10CYP2C9PTGS1PTGS2
SCHEMBL312086 0.85 HSD17B10 (0.68) CA1CA2CA12ALDH1A1HSD17B10
Ammonia Solution, Strong SCHEMBL7644790 0.83 HSD17B10 (0.66) CA1CA2CA12ALDH1A1HSD17B10
SCHEMBL8565803 0.83 ALDH1A1 (0.47) CA1CA2ALDH1A1HSD17B10CYP2C9
Ammonia Solution, Strong SCHEMBL7644798 0.83 HSD17B10 (0.66) CA1CA2CA12ALDH1A1HSD17B10
SCHEMBL7119073 0.82 CA2 (0.57) CA1CA2CA9CA12ALDH1A1
SCHEMBL3527141 0.82 ALDH1A1 (0.70) CA1CA2CA9CA12ALDH1A1
SCHEMBL7145771 0.81 CA2 (0.55) CA1CA2CA9CA12KDM4E
SCHEMBL7917776 0.81 CA1 (0.59) CA1CA2CA9CA12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1127479-C Sulfonylurea derivatives and their use in the control of interleukin-1 activity PFIZER (US) 2003-11-12 CN disclosed
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed
CN-1245490-A Sulfonyl urea derivatives and their use in control of interleukin-1 activity PFIZER (US) 2000-02-23 CN disclosed
EP-0431943-B1 Spiro(pyran)piperidine derivatives MERCK & CO INC (US) 1998-07-15 EP disclosed
US-5633247-A ANTIARRTHYMIA AGENT MERCK & CO., INC. (US) 1997-05-27 US disclosed
CN-1110685-A Nitrogen-containing spiro ring MERCK & CO INC (US) 1995-10-25 CN disclosed
US-5206240-A Antiarrhythmia agents MERCK & CO., INC. (US) 1993-04-27 US disclosed
CN-1053613-A Nitrogen-containing spiro ring MERCK & CO INC (US) 1991-08-07 CN disclosed
EP-0431943-A2 Nitrogen-containing spirocycles MERCK & CO. INC. (US) 1991-06-12 EP disclosed